Decoding 4 Analyst Evaluations For Oscar Health

Loading...
Loading...

Across the recent three months, 4 analysts have shared their insights on Oscar Health OSCR, expressing a variety of opinions spanning from bullish to bearish.

The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 0 3 1 0 0
Last 30D 0 1 1 0 0
1M Ago 0 0 0 0 0
2M Ago 0 1 0 0 0
3M Ago 0 1 0 0 0

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $21.25, along with a high estimate of $24.00 and a low estimate of $20.00. Surpassing the previous average price target of $16.00, the current average has increased by 32.81%.

Breaking Down Analyst Ratings: A Detailed Examination

The perception of Oscar Health by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Stephen Baxter Wells Fargo Raises Overweight $24.00 $20.00
Nathan Rich Goldman Sachs Raises Neutral $21.00 $16.00
John Ransom Raymond James Announces Outperform $20.00 -
Stephen Baxter Wells Fargo Raises Overweight $20.00 $12.00

Key Insights:

  • Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Oscar Health. This insight gives a snapshot of analysts' perspectives on the current state of the company.
  • Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Oscar Health compared to the broader market.
  • Price Targets: Analysts predict movements in price targets, offering estimates for Oscar Health's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.

Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Oscar Health's market standing. Stay informed and make well-considered decisions with our Ratings Table.

Stay up to date on Oscar Health analyst ratings.

Delving into Oscar Health's Background

Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.

Understanding the Numbers: Oscar Health's Finances

Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.

Positive Revenue Trend: Examining Oscar Health's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 45.8% as of 31 March, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.

Net Margin: Oscar Health's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 8.28%, the company may face hurdles in effective cost management.

Return on Equity (ROE): Oscar Health's ROE stands out, surpassing industry averages. With an impressive ROE of 19.32%, the company demonstrates effective use of equity capital and strong financial performance.

Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 4.42%, the company showcases effective utilization of assets.

Debt Management: Oscar Health's debt-to-equity ratio is below the industry average. With a ratio of 0.29, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.

Analyst Ratings: What Are They?

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.

Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.

Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...